echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > In the past month, many pharmaceutical companies announced that they had passed the GMP compliance inspection of drugs

    In the past month, many pharmaceutical companies announced that they had passed the GMP compliance inspection of drugs

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    GMP standards are about ensuring the continuous production of drugs and drugs under the specified quality, and are established to minimize the risk of unqualified drugs in the production process
    .
    GMP encompasses all aspects of requirements, from plant to ground, equipment, personnel and training, hygiene, air and water purification, production and documentation
    .
    According to the combing, in the past month, many pharmaceutical companies announced that they passed the GMP compliance inspection
    .

     
    For example, Fangsheng Pharmaceutical announced on the evening of December 5 that its wholly-owned subsidiary, Hunan Shengkanghua Pharmaceutical Co.
    , Ltd.
    , plans to build the second phase of the international industrial park, with a total investment of about 200 million yuan; Hunan Sheng Green Synthetic Pharmaceutical Company, a wholly-owned subsidiary, plans to build the third phase of the Tongguan Park project, with a total investment of about 145 million yuan
    .
    In addition, the company's traditional Chinese medicine pretreatment and extraction workshop (workshop 201) has passed on-site inspection (i.
    e.
    GMP compliance inspection), indicating that the company's relevant production lines meet GMP requirements, which is conducive to the company's continued stable production capacity
    .
    It is reported that the extraction capacity of the traditional Chinese medicine pretreatment and extraction production line in the traditional Chinese medicine pretreatment and extraction workshop (workshop 201): 3,000 tons/year, and the direct investment related to this inspection is about 21.
    2341 million yuan (unaudited).


     
    Kangyuan Pharmaceutical announced on the evening of November 29 that the company recently received the "Announcement of Drug GMP Compliance Inspection Results (No.
    102 of 2022)"
    issued by the Jiangsu Provincial Drug Administration.
    At present, the company has 333 traditional Chinese medicine formula granule varieties that have passed the listing filing review
    .
    The company received the results of the GMP compliance inspection of drugs this time, indicating that the company's relevant production lines meet the GMP requirements, and the company can officially produce and sell traditional Chinese medicine formula granules
    .
    It is reported that the scope of this inspection includes Chinese medicine formula granules [Chinese medicine pieces (purified, cut, fried, seared, charcoal, steamed, boiled, stewed, boiled), Chinese medicine extraction, granules] (Chinese medicine pretreatment and extraction workshop, granule tea workshop (K6)).


     
    Guizhou Bailing said on the interactive platform on November 29 that the company has completed the GMP certification of 26 production lines through new construction or technological upgrading, including tablets, hard capsules, granules, syrups, soft capsules, pills, tinctures, sprays, decoctions
    。 In order to further meet the needs of capacity improvement, the company has implemented a series of technological transformation and expansion projects in recent years, through the implementation of these projects, it will be conducive to expanding the production scale of the company's proprietary Chinese medicines, and after the completion of the construction of the company's capacity expansion technological transformation project in 2022, the company's previous extraction capacity will be increased from 25,000 tons/year at the current stage to 60,000 tons/year
    .

     
    Saisheng Pharmaceutical announced on November 23 that recently, the company received a notice of the GMP compliance inspection results of its subsidiary, Shenyang Junyuan Pharmaceutical Co.
    , Ltd.
    ("Junyuan Pharmaceutical"); The scope of this examination: liniment, solution (topical, hormones), tinctures (topical, hormones).

    The company said that the on-site compliance inspection of drug GMP this time shows that the relevant dosage form production line of Junyuan Pharmaceutical meets the GMP requirements
    .

     
    GMP standard is a set of mandatory standards applicable to pharmaceutical, food and other industries, requiring enterprises to meet the health quality requirements in accordance with relevant national laws and regulations from raw materials, personnel, facilities and equipment, production process, packaging and transportation, quality control, etc.
    , forming a set of operable operating specifications to help enterprises improve the sanitary environment of enterprises, timely discover problems in the production process, and improve
    them.
    GMP standards are the basic conditions
    that pharmaceutical processing enterprises must meet.

     
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.